{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-04T19:44:39.124213+00:00","company":{"ticker":"KOD","cik":1468748,"company_name":"Kodiak Sciences Inc."},"pagination":{"limit":100,"returned":4,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"earnings_release","fact_key":"f9a774ed701bd6aeb8f5a9012894bb5e0a3788f3","cik":1468748,"ticker":"KOD","company_name":"Kodiak Sciences Inc.","filed_at":"2026-05-07T23:59:59+00:00","payload":{"eps_text":"$0.94 per share on a basic and diluted basis","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"Net loss for the first quarter of 2026 was $58.2 million","period_text":"first quarter ended March 31, 2026","report_date":"2026-05-07","result_type":"reported_results","revenue_text":null},"claim":"Kodiak Sciences Inc. reported first quarter ended March 31, 2026 results: net income Net loss for the first quarter of 2026 was $58.2 million, EPS $0.94 per share on a basic and diluted basis.","evidence_excerpt":"Net loss for the first quarter of 2026 was $58.2 million, or $0.94 per share on a basic and diluted basis, as compared to a net loss of $57.5 million, or $1.09 per share on a basic and diluted basis, for the first quarter of 2025.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-26-211811","anchor_url":"https://secwatch.observer/filing/0001193125-26-211811#claim-f9a774ed701bd6aeb8f5a9012894bb5e0a3788f3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1468748/000119312526211811/0001193125-26-211811-index.htm"},{"fact_type":"earnings_release","fact_key":"7ff12ef75319f3cd877c7336c178c4f5bed322fd","cik":1468748,"ticker":"KOD","company_name":"Kodiak Sciences Inc.","filed_at":"2026-03-31T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"Net loss for the fourth quarter of 2025 was $56.7 million, or $1.04 per share on both a basic and diluted basis","period_text":"the fourth quarter and full year ended December 31, 2025","report_date":"2026-03-31","result_type":"reported_results","revenue_text":null},"claim":"Kodiak Sciences Inc. reported the fourth quarter and full year ended December 31, 2025 results: net income Net loss for the fourth quarter of 2025 was $56.7 million, or $1.04 per share on both a basic and diluted basis.","evidence_excerpt":"On March 31, 2026, Kodiak Sciences Inc. (the “Company”) published a press release reporting the Company’s financial results for the quarter and year ended December 31, 2025 and business highlights.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-26-134854","anchor_url":"https://secwatch.observer/filing/0001193125-26-134854#claim-7ff12ef75319f3cd877c7336c178c4f5bed322fd","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1468748/000119312526134854/0001193125-26-134854-index.htm"},{"fact_type":"earnings_release","fact_key":"b108ec1c9d7691a7d47fad3064e5792ad565df4b","cik":1468748,"ticker":"KOD","company_name":"Kodiak Sciences Inc.","filed_at":"2024-05-15T23:59:59+00:00","payload":{"eps_text":"$0.82 per share on both a basic and diluted basis","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$43.0 million, or $0.82 per share on both a basic and diluted basis","period_text":"the quarter ended March 31, 2024","report_date":"2024-05-15","result_type":"reported_results","revenue_text":null},"claim":"Kodiak Sciences Inc. reported the quarter ended March 31, 2024 results: net income $43.0 million, or $0.82 per share on both a basic and diluted basis, EPS $0.82 per share on both a basic and diluted basis.","evidence_excerpt":"Kodiak Sciences Inc. (Nasdaq: KOD), today reported business highlights and financial results for the quarter ended March 31, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000950170-24-060455","anchor_url":"https://secwatch.observer/filing/0000950170-24-060455#claim-b108ec1c9d7691a7d47fad3064e5792ad565df4b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1468748/000095017024060455/0000950170-24-060455-index.htm"},{"fact_type":"earnings_release","fact_key":"a8575391b1500fe507681188d0b9b33d7ce5855a","cik":1468748,"ticker":"KOD","company_name":"Kodiak Sciences Inc.","filed_at":"2024-03-28T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"the quarter and year ended December 31, 2023","report_date":"2024-03-28","result_type":"reported_results","revenue_text":null},"claim":"Kodiak Sciences Inc. reported financial results for the quarter and year ended December 31, 2023.","evidence_excerpt":"On March 28, 2024, Kodiak Sciences Inc. (the “Company”) published a press release reporting the Company’s financial results for the quarter and year ended December 31, 2023 and business highlights.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000950170-24-037608","anchor_url":"https://secwatch.observer/filing/0000950170-24-037608#claim-a8575391b1500fe507681188d0b9b33d7ce5855a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1468748/000095017024037608/0000950170-24-037608-index.htm"}]}